MedCitizens

StartUPDATES: New developments from healthcare startups

Check out news from Healthmine, Marley Medical, Alloy, Culture Biosciences and more.

Vector illustration - Startup

Healthmine is hosting a free, three-part webinar series throughout November to help health plans prepare for the next measurement year. Register now to gain key insights from the 2022 Star Ratings for Medicare Advantage plans, as well as the best practices to succeed amidst rapid change.

Click here to save your spot.


Propeller Health alumni Chris Hogg, David Hubanks and Joe Slavinsky have founded Marley Medical. The company provides a virtual primary care clinic, focused on people with common chronic diseases, that seeks to reimagine care pathways with the patient in the center, and reestablishing primary care as the foundation of chronic disease management.

The company also closed a $9 million seed round led by Julie Yoo, General Partner at Andreessen Horowitz, and Kristin Baker Spohn, General Partner at CRV. Additional investors include founders, CEOs, investors and digital health professionals including Anne Wojcicki, Bryce Roberts, Christine Lemke, David Van Sickle, Greg Tracy, Halle Tecco, Jesse Waldron, John Lilly, Karan Singh, Malay Gandhi, Misha Chellam, Skip Fleshman, Ted Maidenberg, Thomas Goetz, and Villi Iltchev.

To read more, click here.


Alloy, a new telehealth company targeting the healthcare needs of women over 40, has announced a $3.3 million seed funding round from venture studio Kairos HQ and PACE Healthcare Capital, as it gears up for a launch in the fourth quarter of 2021. The company’s focus is to improve the way menopause is treated.

“We are fiercely dedicated to rewriting the aging narrative for women, and making sure they’re informed on all the options available to help them to feel like their best selves,” says Anne Fulenwider, Alloy co-founder, co-CEO and a former editor-in-chief of women’s magazine Marie Claire. “Alloy exists because too many women haven’t been able to get the treatment they need. We are here to course correct post-reproductive healthcare and we could not be more excited to share this platform with the world.”

To read more, click here.


Culture Biosciences, a company enabling biotech firms to develop and scale manufacturing processes in the cloud, has raised $80 million in a Series B financing round. Northpond Ventures led the round, with participation from Synthesis Capital. Existing investors Cultivian Sandbox Ventures, The Production Board, Craft Ventures, E14 Fund, Box Group, Verily Life Sciences, and Section 32 also contributed.

Andrew Lee of Northpond Ventures will join Culture’s Board of Directors.

“Recently there’s been an explosion in the number of new companies in synthetic biology and biopharmaceuticals, and large multinational corporations are also increasingly participating in this space,” said Will Patrick, CEO and co-founder of Culture Biosciences. “Although demand for biomanufactured products—from food to clothing to vaccines—is surging, there’s a huge gap in the infrastructure required to produce these bioproducts at commercial scale.”

To read more, click here.


Pathway Medical, a medical knowledge startup,  has announced it raised $1.3 million to scale its clinical decision support platform.

The Pathway mobile app, which is available directly to healthcare professionals via the Apple App Store and soon on the Google Play Store, uses natural language processing and machine learning to provide evidence-based answers to clinical questions for the diagnosis and treatment of patients.

Investors include Panache Ventures, Amplify Capital, Desjardins Venture Capital, BoxOne Ventures, and Formentera Capital.

To read more, click here.


Feedtrail, a Raleigh-based software company focused on patient satisfaction and surveys, and Synlab, one of the leading medical diagnostic services providers in Europe, announced an expansion of their partnership to support patient and customer centricity. Committing to Feedtrail as a long-term strategic partner, Synlab aims to further elevate its customer experience, expanding usage of the Feedtrail XM platform across 2,100 sites in 36 countries.

Leveraging the Feedtrail XM platform, hospitals, clinicians, and patients can evaluate the service provided by Synlab in real-time and provide candid feedback.

To read more, click here.

Picture: akindo, Getty Images


This is a paid member feature of MedCitizens. Please submit here and join!

Shares0
Shares0